Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum
暂无分享,去创建一个
[1] P. Nilsson,et al. Pyoderma gangrenosum associated with regional enteritis. Improvement in defective granulocyte function and healing of skin lesions during administration of clofazimine. , 2009, Acta medica Scandinavica.
[2] H. Baddeley,et al. Abdominal pain and malabsorption due to tissue deposition of clofazimine (Lamprene) crystals , 1977 .
[3] Jopling Wh. Complications of treatment with clofazimine (Lamprene: B663). , 1976 .
[4] W. Jopling. Complications of treatment with clofazimine (Lamprene: B663). , 1976, Leprosy Review.
[5] J. Mackey,et al. Clofazimine in the treatment of discoid lupus erythematosus , 1974, The British journal of dermatology.
[6] S. G. Browne,et al. "B 663" in the treatment of leprosy. Preliminary report of a pilot trial. , 1962, Leprosy review.
[7] S. G. Browne,et al. "B 663" in the treatment of leprosy. Supplementary report of the pilot trial. , 1962, Leprosy review.
[8] V. Barry,et al. A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis Activity , 1957, Nature.